Company intelligence / Profile preview

Brazil Wahsun Import & Export

São Paulo, São Paulo, Brazil

Ownership: Private
Development stage: Other

Overview

Brazil Wahsun Import & Export is a Brazilian-based international trading company specializing in the healthcare and pharmaceutical sectors. Founded in 1990, the company facilitates the distribution of pharmaceutical products and medical equipment between Brazil and Asian markets, particularly China. It is notably recognized for its long-term partnership with AXM Pharma for the distribution of Sygen, a GM1 ganglioside product used for treating Parkinson's disease and central nervous system injuries. The company also engages in joint ventures and investments in medical equipment manufacturing in China, acting as a strategic bridge for international healthcare trade.

Therapeutic areas: Neurology
Modalities: Small molecule
Industry: Investors

Partnerships

AXM PharmaTRB Pharma

Beyond the preview

Go deeper on Brazil Wahsun Import & Export.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Brazil Wahsun Import & Export.

Explore the full profile